rs146429605

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS1

This summary comes from the ClinGen Evidence Repository: This pathogenicity assessment is relevant only for malignant hyperthermia susceptibility (MHS) inherited in an autosomal dominant pattern. Variants in RYR1 can also cause other myopathies inherited in an autosomal dominant pattern or in an autosomal recessive pattern. Some of these disorders may predispose individuals to malignant hyperthermia. RYR1 variants may also contribute to a malignant hyperthermia reaction in combination with other genetic and non-genetic factors and the clinician needs to consider such factors in making management decisions. This sequence variant predicts a substitution of Isoleucine with Valine at codon 1571 of the RYR1 protein, p.(Ile1571Val). The maximum allele frequency for this variant among the six major gnomAD populations is NFE: 0.0014, this is considered to be more common than expected for a pathogenic variant causing autosomal dominantly inherited MHS, BS1. This variant has been reported in five unrelated individuals who have a personal or family history of a malignant hyperthermia reaction, all of these individuals had a positive in vitro contracture test (IVCT) or caffeine halothane contracture test (CHCT) result (if the proband was unavailable for testing, a positive diagnostic test result in a mutation-positive relative was counted), (PMID:25958340, PMID:20681998, PMID:25658027, PMID:25735680). However, the high MAF in the NFE population in gnomAD precludes the use of PS4. No functional studies were identified for this variant. This variant does not reside in a hotspot for pathogenic variants that contribute to MHS. A REVEL score of 0.56 supports neither a pathogenic nor a benign status for this variant. Based on using Bayes to combine criteria this variant is assessed as Likely Benign, (PMID:29300386). Criteria implemented: BS1.  LINK:https://erepo.genome.network/evrepo/ui/classification/CA024455/MONDO:0007783/012

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0012 ( 3 hom. )

Consequence

RYR1
NM_000540.3 missense

Scores

1
3
13

Clinical Significance

Likely benign reviewed by expert panel P:1U:16B:8

Conservation

PhyloP100: 2.60

Publications

18 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, ClinGen
  • RYR1-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
NM_000540.3
MANE Select
c.4711A>Gp.Ile1571Val
missense
Exon 33 of 106NP_000531.2P21817-1
RYR1
NM_001042723.2
c.4711A>Gp.Ile1571Val
missense
Exon 33 of 105NP_001036188.1P21817-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
ENST00000359596.8
TSL:5 MANE Select
c.4711A>Gp.Ile1571Val
missense
Exon 33 of 106ENSP00000352608.2P21817-1
RYR1
ENST00000355481.8
TSL:1
c.4711A>Gp.Ile1571Val
missense
Exon 33 of 105ENSP00000347667.3P21817-2
RYR1
ENST00000594335.6
TSL:1
n.4711A>G
non_coding_transcript_exon
Exon 33 of 103ENSP00000470927.2M0R014

Frequencies

GnomAD3 genomes
AF:
0.00109
AC:
166
AN:
152128
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00162
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000895
AC:
150
AN:
167524
AF XY:
0.000934
show subpopulations
Gnomad AFR exome
AF:
0.000102
Gnomad AMR exome
AF:
0.00102
Gnomad ASJ exome
AF:
0.000575
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00146
Gnomad OTH exome
AF:
0.000642
GnomAD4 exome
AF:
0.00121
AC:
1705
AN:
1408196
Hom.:
3
Cov.:
32
AF XY:
0.00125
AC XY:
869
AN XY:
695748
show subpopulations
African (AFR)
AF:
0.0000929
AC:
3
AN:
32306
American (AMR)
AF:
0.00102
AC:
37
AN:
36308
Ashkenazi Jewish (ASJ)
AF:
0.000554
AC:
14
AN:
25268
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36874
South Asian (SAS)
AF:
0.000584
AC:
47
AN:
80466
European-Finnish (FIN)
AF:
0.0000207
AC:
1
AN:
48372
Middle Eastern (MID)
AF:
0.00176
AC:
10
AN:
5686
European-Non Finnish (NFE)
AF:
0.00142
AC:
1540
AN:
1084496
Other (OTH)
AF:
0.000907
AC:
53
AN:
58420
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
112
224
337
449
561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00109
AC:
166
AN:
152246
Hom.:
1
Cov.:
31
AF XY:
0.00109
AC XY:
81
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41548
American (AMR)
AF:
0.00268
AC:
41
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00162
AC:
110
AN:
67992
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00138
Hom.:
1
Bravo
AF:
0.00105
ESP6500AA
AF:
0.000229
AC:
1
ESP6500EA
AF:
0.00129
AC:
11
ExAC
AF:
0.000603
AC:
71
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
6
2
not provided (8)
-
1
5
Malignant hyperthermia, susceptibility to, 1 (6)
-
2
1
not specified (3)
1
1
-
Central core myopathy (2)
-
2
-
RYR1-related disorder (2)
-
1
-
Anterior segment dysgenesis 7 (1)
-
1
-
Congenital myopathy with fiber type disproportion;C1850674:Congenital multicore myopathy with external ophthalmoplegia;C2930980:Malignant hyperthermia, susceptibility to, 1;C5830701:Central core myopathy (1)
-
1
-
RYR1-related myopathy (1)
-
1
-
See cases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.038
T
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
19
DANN
Benign
0.94
DEOGEN2
Benign
0.29
T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.050
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.74
T
M_CAP
Benign
0.080
D
MetaRNN
Benign
0.016
T
MetaSVM
Uncertain
0.18
D
MutationAssessor
Benign
0.49
N
PhyloP100
2.6
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.27
N
REVEL
Uncertain
0.56
Sift
Benign
0.73
T
Polyphen
0.99
D
Vest4
0.65
MVP
0.94
MPC
0.32
ClinPred
0.022
T
GERP RS
4.0
Varity_R
0.061
gMVP
0.21
Mutation Taster
=41/59
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146429605; hg19: chr19-38973933; API